Neurovascular coupling, functional connectivity, and cerebrovascular endothelial extracellular vesicles as biomarkers of mild cognitive impairment.

endothelium extracellular vesicles functional connectivity mild cognitive impairment neurovascular coupling

Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
03 Jul 2024
Historique:
revised: 16 05 2024
received: 16 02 2024
accepted: 22 05 2024
medline: 3 7 2024
pubmed: 3 7 2024
entrez: 3 7 2024
Statut: aheadofprint

Résumé

Mild cognitive impairment (MCI) is a prodromal stage of dementia. Understanding the mechanistic changes from healthy aging to MCI is critical for comprehending disease progression and enabling preventative intervention. Patients with MCI and age-matched controls (CN) were administered cognitive tasks during functional near-infrared spectroscopy (fNIRS) recording, and changes in plasma levels of extracellular vesicles (EVs) were assessed using small-particle flow cytometry. Neurovascular coupling (NVC) and functional connectivity (FC) were decreased in MCI compared to CN, prominently in the left-dorsolateral prefrontal cortex (LDLPFC). We observed an increased ratio of cerebrovascular endothelial EVs (CEEVs) to total endothelial EVs in patients with MCI compared to CN, correlating with structural MRI small vessel ischemic damage in MCI. LDLPFC NVC, CEEV ratio, and LDLPFC FC had the highest feature importance in the random Forest group classification. NVC, CEEVs, and FC predict MCI diagnosis, indicating their potential as markers for MCI cerebrovascular pathology. Neurovascular coupling (NVC) is impaired in mild cognitive impairment (MCI). Functional connectivity (FC) compensation mechanism is lost in MCI. Cerebrovascular endothelial extracellular vesicles (CEEVs) are increased in MCI. CEEV load strongly associates with cerebral small vessel ischemic lesions in MCI. NVC, CEEVs, and FC predict MCI diagnosis over demographic and comorbidity factors.

Identifiants

pubmed: 38958537
doi: 10.1002/alz.14072
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : The American Heart Association
ID : AHA941290
Organisme : The American Heart Association
ID : AHA932980
Organisme : The American Heart Association
ID : 966924
Organisme : The American Heart Association
ID : 23DIVSUP1070991
Organisme : NIA NIH HHS
ID : RF1AG072295
Pays : United States
Organisme : NIA NIH HHS
ID : R01AG055395
Pays : United States
Organisme : NIA NIH HHS
ID : R01AG068295
Pays : United States
Organisme : NIA NIH HHS
ID : K01AG073614
Pays : United States
Organisme : NIA NIH HHS
ID : K01AG073613
Pays : United States
Organisme : NIA NIH HHS
ID : R03AG070479
Pays : United States
Organisme : NIA NIH HHS
ID : R01AG075834
Pays : United States
Organisme : NIA NIH HHS
ID : R21AG080775
Pays : United States
Organisme : Eunice Kennedy Shriver National Institute of Child Health and Human Development
ID : R01HD109157
Organisme : NINDS NIH HHS
ID : R01NS100782
Pays : United States
Organisme : NINDS NIH HHS
ID : RF1NS085002
Pays : United States
Organisme : U.S. Department of Veterans Affairs
ID : CX002578
Organisme : U.S. Department of Veterans Affairs
ID : CX000340
Organisme : NCI NIH HHS
ID : R01CA255840
Pays : United States
Organisme : Oklahoma Shared Clinical and Translational Resources (OSCTR)
Organisme : NIGMS NIH HHS
ID : U54GM104938
Pays : United States
Organisme : NIA-funded Geroscience Training Program in Oklahoma
ID : T32AG052363

Informations de copyright

© 2024 The Author(s). Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.

Références

Nichols E, Steinmetz JD, Vollset SE, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022;7:e105‐e125. doi:10.1016/S2468‐2667(21)00249‐8
Mattson MP, Arumugam TV. Hallmarks of brain aging: adaptive and pathological modification by metabolic states. Cell Metab. 2018;27:1176‐1199. doi:10.1016/j.cmet.2018.05.011
Perneczky R. Dementia treatment versus prevention. Dialogues Clin Neurosci. 2019;21:43‐51. 10.31887/DCNS.2019.21.1/rperneczky
Bai W, Chen P, Cai H, et al. Worldwide prevalence of mild cognitive impairment among community dwellers aged 50 years and older: a meta‐analysis and systematic review of epidemiology studies. Age Ageing. 2022;51. doi:10.1093/ageing/afac173
Knopman DS, Amieva H, Petersen RC, et al. Alzheimer disease. Nat Rev Dis Primers . 2021;7:33. doi:10.1038/s41572‐021‐00269‐y
Reinvang I, Grambaite R, Espeseth T. Executive dysfunction in MCI: subtype or early symptom. J Alzheimer's Dis. 2012;2012:936272. doi:10.1155/2012/936272
Campbell NL, Unverzagt F, LaMantia MA, Khan BA, Boustani MA. Risk factors for the progression of mild cognitive impairment to dementia. Clin Geriatr Med. 2013;29:873‐893. doi:10.1016/j.cger.2013.07.009
Zhu WM, Neuhaus A, Beard DJ, Sutherland BA, DeLuca GC. Neurovascular coupling mechanisms in health and neurovascular uncoupling in Alzheimer's disease. Brain. 2022;145:2276‐2292. doi:10.1093/brain/awac174
Tarantini S, Tran CHT, Gordon GR, Ungvari Z, Csiszar A. Impaired neurovascular coupling in aging and Alzheimer's disease: contribution of astrocyte dysfunction and endothelial impairment to cognitive decline. Exp Gerontol. 2017;94:52‐58. doi:10.1016/j.exger.2016.11.004
Mukli P, Pinto CB, Owens CD, et al. Impaired neurovascular coupling and increased functional connectivity in the frontal cortex predict age‐related cognitive dysfunction. Adv Sci (Weinh). 2023:e2303516. doi:10.1002/advs.202303516
Kisler K, Nelson AR, Montagne A, Zlokovic BV. Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat Rev Neurosci. 2017;18:419‐434. doi:10.1038/nrn.2017.48
Friston KJ, Kahan J, Biswal B, Razi A. A DCM for resting state fMRI. Neuroimage. 2014;94:396‐407. doi:10.1016/j.neuroimage.2013.12.009
Farràs‐Permanyer L, Guàrdia‐Olmos J, Peró‐Cebollero M. Mild cognitive impairment and fMRI studies of brain functional connectivity: the state of the art. Front Psychol. 2015;6:1095. doi:10.3389/fpsyg.2015.01095
Lin L, Xing G, Han Y. Advances in resting state neuroimaging of mild cognitive impairment. Front Psychiatry. 2018;9:671. doi:10.3389/fpsyt.2018.00671
Wolters FJ, Zonneveld HI, Hofman A, et al. Cerebral perfusion and the risk of dementia. Circulation. 2017;136:719‐728. doi:10.1161/CIRCULATIONAHA.117.027448
Tang T, Huang L, Zhang Y, Li Z, Liang S. Aberrant pattern of regional cerebral blood flow in mild cognitive impairment: a meta‐analysis of arterial spin labeling magnetic resonance imaging. Front Aging Neurosci. 2022;14. doi:10.3389/fnagi.2022.961344
Calcetas AT, Thomas KR, Edmonds EC, et al. Increased regional white matter hyperintensity volume in objectively‐defined subtle cognitive decline and mild cognitive impairment. Neurobiol Aging. 2022;118:1‐8. doi:10.1016/j.neurobiolaging.2022.06.002
Li Q, Yang Y, Reis C, et al. Cerebral small vessel disease. Cell Transplant. 2018;27:1711‐1722. doi:10.1177/0963689718795148
Huang H, Zhao K, Zhu W, Li H, Zhu W. Abnormal cerebral blood flow and functional connectivity strength in subjects with white matter hyperintensities. Front Neurol. 2021;12:1‐13. doi:10.3389/fneur.2021.752762
Lee Y, EL Andaloussi S, Wood MJA. Exosomes and microvesicles: extracellular vesicles for genetic information transfer and gene therapy. Hum Mol Genet. 2012;21:R125‐R134. doi:10.1093/hmg/dds317
Jansen F, Nickenig G, Werner N. Extracellular vesicles in cardiovascular disease. Circ Res. 2017;120:1649‐1657. doi:10.1161/CIRCRESAHA.117.310752
Viswanathan A, Rocca WA, Tzourio C. Vascular risk factors and dementia: how to move forward? Neurology. 2009;72:368‐374. doi:10.1212/01.wnl.0000341271.90478.8e
Mazzucco M, Mannheim W, Shetty SV, Linden JR. CNS endothelial derived extracellular vesicles are biomarkers of active disease in multiple sclerosis. Fluids Barriers CNS. 2022;19:13. doi:10.1186/s12987‐021‐00299‐4
Visconte C, Golia MT, Fenoglio C, et al. Plasma microglial‐derived extracellular vesicles are increased in frail patients with Mild Cognitive Impairment and exert a neurotoxic effect. Geroscience. 2023;45:1557‐1571. doi:10.1007/s11357‐023‐00746‐0
Zhao Z, Nelson AR, Betsholtz C, Zlokovic BV. Establishment and dysfunction of the blood‐brain barrier. Cell. 2015;163:1064‐1078.
Kynast J, Lampe L, Luck T, et al. White matter hyperintensities associated with small vessel disease impair social cognition beside attention and memory. J Cereb Blood Flow Metab. 2018;38:996‐1009. doi:10.1177/0271678x17719380
Owens CD, Bonin Pinto C, Mukli P, et al. Vascular mechanisms leading to progression of mild cognitive impairment to dementia after COVID‐19: protocol and methodology of a prospective longitudinal observational study. PLOS ONE. 2023;18:e0289508. doi:10.1371/journal.pone.0289508
Haatveit BC, Sundet K, Hugdahl K, Ueland T, Melle I, Andreassen OA. The validity of d prime as a working memory index: results from the “Bergen n‐back task”. J Clin Exp Neuropsychol. 2010;32:871‐880. doi:10.1080/13803391003596421
Santosa H, Zhai X, Fishburn F, Huppert T. The NIRS Brain AnalyzIR Toolbox. Algorithms. 2018;11:73.
Mukli P, Csipo T, Lipecz A, et al. Sleep deprivation alters task‐related changes in functional connectivity of the frontal cortex: a near‐infrared spectroscopy study. Brain Behav. 2021;11:e02135. doi:10.1002/brb3.2135
Kocsis L, Herman P, Eke A. The modified Beer‐Lambert law revisited. Phys Med Biol. 2006;51:N91‐N98. doi:10.1088/0031‐9155/51/5/n02
Racz FS, Mukli P, Nagy Z, Eke A. Increased prefrontal cortex connectivity during cognitive challenge assessed by fNIRS imaging. Biomed Opt Express. 2017;8:3842‐3855. doi:10.1364/boe.8.003842
Cheng Y, Zeng Q, Han Q, Xia W. Effect of pH, temperature and freezing‐thawing on quantity changes and cellular uptake of exosomes. Protein Cell. 2018;10:295‐299. doi:10.1007/s13238‐018‐0529‐4
Guo Y, Pai M, Xue B, Lu W. Bidirectional association between depressive symptoms and mild cognitive impairment over 20 years: evidence from the Health and Retirement Study in the United States. J Affect Disord. 2023;338:449‐458. doi:10.1016/j.jad.2023.06.046
Harrington KD, Dang C, Lim YY, et al. The effect of preclinical Alzheimer's disease on age‐related changes in intelligence in cognitively normal older adults. Intelligence. 2018;70:22‐29. doi:10.1016/j.intell.2018.07.004
Barbey AK, Koenigs M, Grafman J. Dorsolateral prefrontal contributions to human working memory. Cortex. 2013;49:1195‐1205. doi:10.1016/j.cortex.2012.05.022
Caruso S, Poon IKH. Apoptotic cell‐derived extracellular vesicles: more than just debris. Front Immunol. 2018;9:1486. doi:10.3389/fimmu.2018.01486
Jaeggi SM, Buschkuehl M, Perrig WJ, Meier B. The concurrent validity of the N‐back task as a working memory measure. Memory. 2010;18:394‐412. doi:10.1080/09658211003702171
Hackett K, Krikorian R, Giovannetti T, et al. Utility of the NIH Toolbox for assessment of prodromal Alzheimer's disease and dementia. Alzheimers Dement (Amst). 2018;10:764‐772. doi:10.1016/j.dadm.2018.10.002
Zhang H, Wang Y, Lyu D, et al. Cerebral blood flow in mild cognitive impairment and Alzheimer's disease: a systematic review and meta‐analysis. Ageing Res Rev. 2021;71:101450. doi:10.1016/j.arr.2021.101450
Korte N, Nortley R, Attwell D. Cerebral blood flow decrease as an early pathological mechanism in Alzheimer's disease. Acta Neuropathol. 2020;140:793‐810. doi:10.1007/s00401‐020‐02215‐w
Nakamura S, Yomota S, Ito H, et al. A novel cognitive function scale using functional near‐infrared spectroscopy for evaluating cognitive dysfunction. J Alzheimers Dis. 2021;81:1579‐1588. doi:10.3233/jad‐210072
Li R, Rui G, Chen W, Li S, Schulz PE, Zhang Y. Early detection of Alzheimer's disease using non‐invasive near‐infrared spectroscopy. Front Aging Neurosci. 2018;10:366. doi:10.3389/fnagi.2018.00366
Niu HJ, Li X, Chen YJ, Ma C, Zhang JY, Zhang ZJ. Reduced frontal activation during a working memory task in mild cognitive impairment: a non‐invasive near‐infrared spectroscopy study. CNS Neurosci Ther. 2013;19:125‐131. doi:10.1111/cns.12046
Yeung MK, Sze SL, Woo J, et al. Reduced frontal activations at high working memory load in mild cognitive impairment: near‐infrared spectroscopy. Dement Geriatr Cogn Disord. 2016;42:278‐296. doi:10.1159/000450993
Sorond FA, Hurwitz S, Salat DH, Greve DN, Fisher ND. Neurovascular coupling, cerebral white matter integrity, and response to cocoa in older people. Neurology. 2013;81:904‐909. doi:10.1212/WNL.0b013e3182a351aa
Yu JW, Lim SH, Kim B, et al. Prefrontal functional connectivity analysis of cognitive decline for early diagnosis of mild cognitive impairment: a functional near‐infrared spectroscopy study. Biomed Opt Express. 2020;11:1725‐1741. doi:10.1364/boe.382197
Nguyen T, Kim M, Gwak J, et al. Investigation of brain functional connectivity in patients with mild cognitive impairment: a functional near‐infrared spectroscopy (fNIRS) study. J Biophotonics. 2019;12:e201800298. doi:10.1002/jbio.201800298
Gómez‐Ramírez J, Ávila‐Villanueva M, Fernández‐Blázquez MÁ. Selecting the most important self‐assessed features for predicting conversion to mild cognitive impairment with random forest and permutation‐based methods. Sci Rep. 2020;10:20630. doi:10.1038/s41598‐020‐77296‐4
Zhong X, Yu J, Jiang F, et al. A risk prediction model based on machine learning for early cognitive impairment in hypertension: development and validation study. Front Public Health. 2023;11:1143019. doi:10.3389/fpubh.2023.1143019
Khazaee A, Ebrahimzadeh A, Babajani‐Feremi A. Application of advanced machine learning methods on resting‐state fMRI network for identification of mild cognitive impairment and Alzheimer's disease. Brain Imaging Behav. 2016;10:799‐817. doi:10.1007/s11682‐015‐9448‐7
Vipin A, Loke YM, Liu S, et al. Cerebrovascular disease influences functional and structural network connectivity in patients with amnestic mild cognitive impairment and Alzheimer's disease. Alzheimers Res Ther. 2018;10:82. doi:10.1186/s13195‐018‐0413‐8
Doyle LM, Wang MZ. Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells. 2019;8:1‐24. doi:10.3390/cells8070727
Pulliam L, Sun B, Mustapic M, Chawla S, Kapogiannis D. Plasma neuronal exosomes serve as biomarkers of cognitive impairment in HIV infection and Alzheimer's disease. J Neurovirol. 2019;25:702‐709. doi:10.1007/s13365‐018‐0695‐4
McKeever PM, Schneider R, Taghdiri F, et al. MicroRNA Expression levels are altered in the cerebrospinal fluid of patients with young‐onset Alzheimer's disease. Mol Neurobiol. 2018;55:8826‐8841. doi:10.1007/s12035‐018‐1032‐x
Liu YJ, Wang C. A review of the regulatory mechanisms of extracellular vesicles‐mediated intercellular communication. Cell Commun Signal. 2023;21:77. doi:10.1186/s12964‐023‐01103‐6
Tarantini S, Valcarcel‐Ares MN, Toth P, et al. Nicotinamide mononucleotide (NMN) supplementation rescues cerebromicrovascular endothelial function and neurovascular coupling responses and improves cognitive function in aged mice. Redox Biol. 2019;24:101192. doi:10.1016/j.redox.2019.101192
Cano A, Esteban‐de‐Antonio E, Bernuz M, et al. Plasma extracellular vesicles reveal early molecular differences in amyloid positive patients with early‐onset mild cognitive impairment. J Nanobiotechnology. 2023;21:54. doi:10.1186/s12951‐023‐01793‐7
Sharygin D, Koniaris LG, Wells C, Zimmers TA, Hamidi T. Role of CD14 in human disease. Immunology. 2023;169:260‐270. doi:10.1111/imm.13634

Auteurs

Cameron D Owens (CD)

Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Camila Bonin Pinto (CB)

Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Peter Mukli (P)

Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Department of Physiology, Faculty of Medicine, Semmelweis University, Budapest, Hungary.
International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Public Health, Semmelweis University, Budapest, Hungary.

Rafal Gulej (R)

Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Faddi Saleh Velez (FS)

Department of Neurology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Sam Detwiler (S)

Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Lauren Olay (L)

Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Jordan R Hoffmeister (JR)

Neuropsychology Service, Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Zsofia Szarvas (Z)

Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Public Health, Semmelweis University, Budapest, Hungary.

Mihaly Muranyi (M)

Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Public Health, Semmelweis University, Budapest, Hungary.

Anna Peterfi (A)

Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Public Health, Semmelweis University, Budapest, Hungary.

Ana Clara da C Pinaffi-Langley (ACDC)

Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Department of Nutritional Sciences, College of Allied Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Cheryl Adams (C)

Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Jason Sharps (J)

Department of Neurology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Zalan Kaposzta (Z)

Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Public Health, Semmelweis University, Budapest, Hungary.

Calin I Prodan (CI)

Department of Neurology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Veterans Affairs Medical Center, Oklahoma City, Oklahoma, USA.

Angelia C Kirkpatrick (AC)

Veterans Affairs Medical Center, Oklahoma City, Oklahoma, USA.
Cardiovascular Disease Section, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Stefano Tarantini (S)

Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Public Health, Semmelweis University, Budapest, Hungary.
Department of Health Promotion Sciences, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Anna Csiszar (A)

Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Public Health, Semmelweis University, Budapest, Hungary.

Zoltan Ungvari (Z)

Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
International Training Program in Geroscience, Doctoral School of Basic and Translational Medicine/Department of Public Health, Semmelweis University, Budapest, Hungary.
Department of Health Promotion Sciences, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Ann L Olson (AL)

Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Guangpu Li (G)

Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Priya Balasubramanian (P)

Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Veronica Galvan (V)

Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Andrew Bauer (A)

Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Zachary A Smith (ZA)

Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Tarun W Dasari (TW)

Cardiovascular Disease Section, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Shawn Whitehead (S)

Vulnerable Brain Laboratory, Department of Anatomy & Cell Biology, Schulich School of Medicine & Dentistry, London, ON, Canada.

Manoj R Medapti (MR)

Vulnerable Brain Laboratory, Department of Anatomy & Cell Biology, Schulich School of Medicine & Dentistry, London, ON, Canada.

Fanny M Elahi (FM)

Icahn School of Medicine at Mount Sinai, New York, New York, USA.
James J. Peters Department of Veterans Affairs Medical Center, Bronx, New York, USA.

Aikaterini Thanou (A)

Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma, USA.
Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Andriy Yabluchanskiy (A)

Oklahoma Center for Geroscience and Healthy Brain Aging, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Vascular Cognitive Impairment and Neurodegeneration Program, Department of Neurosurgery, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Department of Health Promotion Sciences, College of Public Health, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Peggy and Charles Stephenson Cancer Center, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Classifications MeSH